title: Effective treatment of infant botulism on day 13 after symptom onset with human botulism antitoxin.
authors.affiliation: Department of Infectious Diseases, Princess Margaret Hospital, Perth, Western Australia, Australia.|Pathwest Microbiology Department, QE11 Medical Centre, Perth, Western Australia, Australia.|Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
authors.forename: Anita J
authors.initials: AJ
authors.lastname: Campbell
authors.affiliation: Department of Paediatric Intensive Care, Princess Margaret Hospital, Perth, Western Australia, Australia.
authors.forename: Geoff
authors.initials: G
authors.lastname: Knight
authors.affiliation: Department of Neurology, Princess Margaret Hospital, Perth, Western Australia, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Walsh
authors.affiliation: Department of Infectious Diseases, Princess Margaret Hospital, Perth, Western Australia, Australia.|Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.|School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia.|Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
authors.forename: Asha C
authors.initials: AC
authors.lastname: Bowen
mesh_terms: D001904:Botulinum Antitoxin / Q000008:administration & dosage; D001906:Botulism / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D003014:Clostridium botulinum / Q000187:drug effects / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007223:Infant; D016896:Treatment Outcome
chemical_list: D001904:Botulinum Antitoxin; D007136:Immunoglobulins; C068584:botulism immune globulin